Pharmaceutical

Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies

Backed by Victory Square, Pawsible combines capital, incubation, and distribution to accelerate diagnostics, AI, insurance, and wellness innovation in the…

3 months ago

Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies

Backed by Victory Square, Pawsible combines capital, incubation, and distribution to accelerate diagnostics, AI, insurance, and wellness innovation in the…

3 months ago

Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI

Serving 80% of the largest home care networks across North America, Sensi.AI is the new standard in senior care PALO…

3 months ago

Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI

Serving 80% of the largest home care networks across North America, Sensi.AI is the new standard in senior care PALO…

3 months ago

AMC Health Appoints Alan Petrazzi as Executive Vice President, Government Division

Bringing decades of VA and federal healthcare leadership, Petrazzi will drive AMC Health's next phase of innovation and impact across…

3 months ago

AMC Health Appoints Alan Petrazzi as Executive Vice President, Government Division

Bringing decades of VA and federal healthcare leadership, Petrazzi will drive AMC Health's next phase of innovation and impact across…

3 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company…

3 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company…

3 months ago

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell…

3 months ago

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, leading to cell…

3 months ago